Ouro Medicines Takes Bold Step with OM336
Category : ODD/BTA/FTA Status 6 August 2025Biotech startup Ouro Medicines has launched a multi-national clinical trial for OM336, a bispecific...
Odd Bta Fta Status
Shanton Pharma’s SAP-001 Receives FDA Fast Track D...
Category : ODD/BTA/FTA Status 28 July 2025Shanton Pharma, a clinical-stage biotech company focused on novel therapies for gout, has announced...
FDA Grants Orphan Drug Status to Sanofi's Rilzabru...
Category : ODD/BTA/FTA Status 5 June 2025The US Food and Drug Administration (FDA) has granted orphan drug designation to rilzabrutinib, a no...
FDA Grants Breakthrough Status to Tinlarebant for...
Category : ODD/BTA/FTA Status 24 May 2025Belite Bio, Inc., a clinical-stage biopharmaceutical company focused on treating degenerative retina...
Alterity’s ATH434 Gets FDA Fast Track for Multiple...
Category : ODD/BTA/FTA Status 6 May 2025Alterity Therapeutics has been granted Fast Track designation by the U.S. Food and Drug Administrati...
Latest Newsletter Post
-
AMI Pharm’s AYP-101 Enters Phase 3:..
12 August 2025
-
GC Biopharma Study Confirms Stabili..
12 August 2025
-
Zydus Lifesciences Secures USFDA Ap..
12 August 2025
-
FOPE–CIPI–DCGI Meet Strengthens Ind..
12 August 2025
-
Assembly Biosciences Reports Positi..
12 August 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com